Feminismo, traduccióón cultural y traicióón en Malinche de Laura Esquivel

2010 ◽  
Vol 26 (1) ◽  
pp. 111-127 ◽  
Author(s):  
Ricardo F. Vivancos Péérez
Keyword(s):  
Visual Representations ◽  
Laura Esquivel ◽  
Cultural Translation ◽  
The Novel ◽  
The U.S

This essay explores the complexity of Laura Esquivel's conciliatory approach to the figure of Malinche in her novel Malinche (2006). I read the text in relation to textual and visual representations by Mexican and Chicana feminists. I also analyze the first three editions of the novel in the U.S. and in Mexico. As a result, I analyze symbolic betrayals that have to do with processes of cultural translation. In this context, I discuss the function of Esquivel as a writer in-between cultures who has the authority to design the plot and to be a traitor, but may also be betrayed in the process.

scholarly journals Belonging in the Coronaverse: Will There Be Time?

2021 ◽  
Vol 1 (1) ◽  
pp. 100-115
Author(s):  
Kate Fischer ◽  
Malika Rakhmonova ◽  
Mike Tran
Keyword(s):  
College Experience ◽  
The United States ◽  
Limited Time ◽  
The Novel ◽  
Residential University ◽  
To Come ◽  
Novel Coronavirus ◽  
University Experience ◽  
The U.S ◽  
Older Siblings

Abstract Since the spring of 2020 SARS-CoV-2, the novel coronavirus, has upended lives and caused a rethinking of nearly all social behaviors in the United States. This paper examines the ways in which the pandemic, shutdown, and gradual move towards “normal” have laid bare and obfuscated societal pressures regarding running out of time as it pertains to the residential university experience. Promised by movies, television, and older siblings and friends as a limited-time offer, the “typical” college experience is baked into the U.S. imaginary, reinforcing a host of notions of who “belongs” on campus along lines of race, class, and age. Fed a vision of what their whole lives “should be”, students who enter a residential four-year college are already imbued with a nostalgia for what is yet to come, hailed, in Althusser’s (2006[1977]) sense, as university subjects even before their first class. The upheaval of that subjecthood during the pandemic has raised important questions about the purpose of the college experience as well as how to belong to a place that is no longer there.

The Prophet Today: The Novel in Distress

2019 ◽  
pp. 210-225
Author(s):  
Maya I. Kesrouany
Keyword(s):  
Cultural Translation ◽  
The Novel ◽  
Critical Approach ◽  
Original Source ◽  
The 1950S ◽  
Egyptian Literature ◽  
Universal Reason

The conclusion historicizes these translations in the story of the Arabic novel before the 1950s, after which the novel becomes canonised. Colonial translation promised facts and truths based on the European master-text, and some Arab reformists confirmed the superiority of philosophy to religion, and hence science to Islam, but the translations complicate such neat cultural translation. The novel is born somewhere in between the original and translation, obfuscating intentionally the original source of which becomes secondary to the process of its adaptation and transmission. The reformist aspirations of the authors remain unrealised much like a perfect emulation of the prophet. Finally, it interrogates the dominant critical approach to these modernist intellectuals as secularising liberals who intentionally separated religion from literature by adopting the reductive Western humanisation of the prophet. The translations reveal how they trespass the separation between literary and religious interpretation bringing the stakes of narrative representation to bear on European ideals of subjectivity and universal reason. In this transgressive space, precisely the incubator of “modern” Egyptian literature, translation becomes neither domesticating nor foreignising but a space where various representational claims are simultaneously adapted and contested.

scholarly journals Activity of Ceftolozane-Tazobactam (C/T) against Escherichia coli Isolates from U.S. Veterans in Relation to Co-resistance and Sequence Type 131 (ST131) H30/H30Rx Status

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S374-S374
Author(s):  
Brian D Johnston ◽  
Paul Thuras ◽  
James R Johnson
Keyword(s):  
Significant Variation ◽  
Multidrug Resistant ◽  
Sequence Type ◽  
Clinical Isolates ◽  
The Novel ◽  
Total Resistance ◽  
Research Support ◽  
E Coli ◽  
The U.S ◽  
Research Grant

Abstract Background E. coli ST131, with its resistance-associated H30 and H30Rx clonal subsets, causes most antimicrobial-resistant E. coli infections, especially among veterans. The activity of the novel combination agent C/T against ST131 is undefined. Methods E. coli clinical isolates (n = 595), including (per VAMC) 10 each ciprofloxacin-resistant and susceptible isolates, plus archived ESBL isolates, were collected from 24 VAMCs across the U.S. (2011). ST131, H30, and H30Rx were detected by clonal PCR. Microdilution MICs were determined for C/T and 5 comparators (piperacillin-tazobactam [TZP], levofloxacin [LVX], gentamicin [GEN], ceftazidime [CAZ], and meropenem [MEM]). Categorical resistance and MICs were compared statistically with resistance category and H30/H30Rx status. Results Total resistance prevalence was < 5% for C/T (3.5%) and MEM (0%), vs. from 7.9% (TZP) to 59% (LVX) for other comparators (Table 1). Resistance prevalence generally increased by resistance category from FQ-S through FQ-R to ESBL, and by clonal subgroup from non-H30 through H30 to H30Rx. Conclusion C/T is broadly active against E. coli clinical isolates from veterans, notwithstanding significant variation by resistance category and ST131-H30/H30Rx status; it outperformed all non-carbapenem comparators. C/T should prove useful as a carbapenem-sparing agent against multidrug-resistant E. coli ST131 infections. Disclosures B. D. Johnston, Merck Sharpe & Dohme, Corp.: Collaborator, Research support Actavis: Collaborator, Research support; J. R. Johnson, Merck: Grant Investigator, Research grant Grant Investigator, Research grant

scholarly journals Telehealth transformation: COVID-19 and the rise of virtual care

2020 ◽  
Vol 27 (6) ◽  
pp. 957-962 ◽  
Author(s):  
Jedrek Wosik ◽  
Marat Fudim ◽  
Blake Cameron ◽  
Ziad F Gellad ◽  
Alex Cho ◽  
...  
Keyword(s):  
Healthcare System ◽  
Delivery System ◽  
Outpatient Care ◽  
Healthcare Delivery ◽  
The Novel ◽  
Healthcare Organizations ◽  
Healthcare Delivery System ◽  
Virtual Care ◽  
Novel Coronavirus ◽  
The U.S

Abstract The novel coronavirus disease-19 (COVID-19) pandemic has altered our economy, society, and healthcare system. While this crisis has presented the U.S. healthcare delivery system with unprecedented challenges, the pandemic has catalyzed rapid adoption of telehealth, or the entire spectrum of activities used to deliver care at a distance. Using examples reported by U.S. healthcare organizations, including ours, we describe the role that telehealth has played in transforming healthcare delivery during the 3 phases of the U.S. COVID-19 pandemic: (1) stay-at-home outpatient care, (2) initial COVID-19 hospital surge, and (3) postpandemic recovery. Within each of these 3 phases, we examine how people, process, and technology work together to support a successful telehealth transformation. Whether healthcare enterprises are ready or not, the new reality is that virtual care has arrived.

scholarly journals 86. Access to Antimicrobial Susceptibility Testing for Novel Gram-Negative Antibiotics

2021 ◽  
Vol 8 (Supplement_1) ◽  
pp. S159-S159
Author(s):  
Yuman Lee ◽  
Juliette Kim ◽  
Nicole Bradley
Keyword(s):  
Antimicrobial Susceptibility ◽  
Susceptibility Testing ◽  
Antimicrobial Susceptibility Testing ◽  
Research Network ◽  
Novel Agents ◽  
The Novel ◽  
Gram Negative ◽  
Electronic Survey ◽  
Antimicrobial Regimen ◽  
The U.S

Abstract Background Antimicrobial susceptibility testing (AST) is critical in identifying the optimal antimicrobial regimen for individual patients with serious gram-negative infections. Limitations to AST for newly developed antibiotics include the lack of commercially available AST methods, challenges of implementation due to regulations, and delays in obtaining results. The purpose of this study was to evaluate the access to AST for cefiderocol (FDC), imipenem-relebactam (IPR), meropenem-vaborbactam (MEV), and eravacycline (ERV) in hospitals across the U.S. Methods An electronic survey was distributed to the American College of Clinical Pharmacist Infectious Diseases Practice and Research Network in May 2021. Hospital baseline demographics and current practices were collected. Results Based on 50 responses, specimens were sent to in-house microbiology labs (37, 74%), core microbiology labs (8, 16%), and 3rd party reference microbiology labs (5, 10%). AST for FDC was performed by 13 (35%) in-house labs, 4 (50%) core labs, and 1 (20%) reference lab. AST for IPR was performed by 11 (30%) in-house labs, 2 (25%) core labs, and 1 (20%) reference lab. AST for MEV was performed by 25 (68%) in-house labs, 3 (37.5%) core labs, and 1 (20%) reference lab. AST for ERV was performed by 1 (20%) in-house lab, 1 (20%) core lab, and 0 reference labs. 15 (30%) respondents were not able to get AST for any of the novel agents at their respective microbiology labs. Turn-around-times (TATs) for FDC, IPR, MEV, and ERV were ≥72 hours for 33 (66%), 35 (70%), 21 (42%), and 35 (70%) hospitals, respectively. When compared with 3rd party reference labs, in-house labs with the ability to perform AST for these novel agents had significantly shorter TATs (p< 0.05). The average number of requests for AST for these novel agents was 20 times a year with an average of 113 minutes spent per patient on the coordination of AST. Conclusion Access to AST for these novel agents varied across hospitals in the U.S. Nearly 1/3 of the respondents were not able to obtain AST for these agents at all. Long TATs exist and a great deal of time is spent per patient for coordinating AST for these novel agents. There is a crucial need for a multidisciplinary, collaborative approach to resolve the challenges in obtaining AST for newly developed antibiotics to provide patient care. Disclosures All Authors: No reported disclosures

scholarly journals COVID-19 and consumer demand for local meat products in South Carolina

2021 ◽  
pp. 1-6
Author(s):  
Steven Richards ◽  
Michael Vassalos
Keyword(s):  
South Carolina ◽  
Supply Chain ◽  
Food Supply ◽  
Local Food ◽  
Stress Test ◽  
Meat Products ◽  
The Novel ◽  
Food Supply Chain ◽  
Novel Coronavirus ◽  
The U.S

The emergence of the novel coronavirus (COVID-19) pandemic and the associated economic disrup­tions have challenged local food producers, distributors, retailers, and restaurants since March 2020. COVID-19 was a stress test for the U.S. local food supply chain, exposing vulnerabilities whose impacts have varied by region and sector. Some local producers saw sales fall in 2020 due to COVID-19 restric­tions and consumer foot traffic changes (O’Hara, Woods, Dutton, & Stavely, 2021). In other areas, local food producers were able to pivot from collapsing market channels by finding opportunities elsewhere (Thilmany, Canales, Low, & Boys, 2020).

scholarly journals Impact of Vaccination on the COVID-19 Pandemic: Evidence from U.S. States

2021 ◽  
Author(s):  
Xiao Chen ◽  
Hanwei Huang ◽  
Jiandong Ju ◽  
Ruoyan Sun ◽  
Jialiang Zhang
Keyword(s):  
Herd Immunity ◽  
Sir Model ◽  
Health Policies ◽  
Vaccine Hesitancy ◽  
The Novel ◽  
Vaccination Programs ◽  
Public Health Policies ◽  
Percentage Points ◽  
Novel Coronavirus ◽  
The U.S

Abstract Governments worldwide are implementing mass vaccination programs in an effort to end the novel coronavirus (COVID-19) pandemic. Here, we evaluated the effectiveness of the COVID-19 vaccination program and predicted the path to herd immunity in the U.S. We estimated that vaccination reduced the total number of new cases by 4.4 million (from 33.0 to 28.6 million), prevented approximately 0.12 million hospitalizations (from 0.89 to 0.78 million), and decreased the population infection rate by 1.34 percentage points (from 10.10–8.76%). We built a Susceptible-Infected-Recovered (SIR) model with vaccination to predict herd immunity. Our model predicts that the U.S. can achieve herd immunity by the last week of July 2021, with a cumulative vaccination coverage of 60.2%. Herd immunity could be achieved earlier with a faster vaccination pace, lower vaccine hesitancy, and higher vaccine effectiveness. These findings improve our understanding of the COVID-19 vaccination and can inform future public health policies.

scholarly journals Messaging Mask Wearing During the COVID-19 Crisis: Ideological Differences

2020 ◽  
pp. 1-11 ◽  
Author(s):  
Stephen M. Utych
Keyword(s):  
Regulatory Focus ◽  
The Novel ◽  
Regulatory Focus Theory ◽  
The Public ◽  
Prevention Messages ◽  
Ideological Differences ◽  
Theoretical Predictions ◽  
Novel Coronavirus ◽  
The U.S ◽  
Focus Theory

Abstract As the U.S. Government works to slow the spread of the novel coronavirus, messaging is important in getting individuals to comply with public health recommendations, especially as the response from the public seems to be polarized along partisan and ideological lines. Using a recent Centers for Disease Control recommendation of wearing facemasks, I use Regulatory Focus Theory to predict that conservatives will be more responsive to messages related to promotion, while liberals are more responsive to messages related to prevention. Using a pre-registered experimental design, I find no evidence that prevention messages influence attitudes toward mask wearing. Promotion messages, however, cause conservatives to become less supportive of mask wearing, in contrast to theoretical predictions. These findings suggest that, related to messaging about mask wearing, strong ideological differences do not emerge related to the focus of the message.

Rapid Development and Deployment of Respiratory Evaluation Clinics in Response to the COVID-19 Pandemic to Keep Staff and Patients Safe

2021 ◽  
pp. 38-42
Author(s):  
Charles Haddad ◽  
Christopher Scuderi ◽  
Judelle Haddad-Lacle ◽  
Reetu Grewal ◽  
Jeffrey Jacqmein ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Rapid Development ◽  
Lessons Learned ◽  
The Novel ◽  
Global Pandemic ◽  
Vulnerable Patients ◽  
The World ◽  
Novel Coronavirus ◽  
Geographical Locations ◽  
The U.S

The world as we knew it changed at the beginning of 2020 with the explosion of the global pandemic caused by SARS-CoV-2, a.k.a. COVID-19. As of January 10, 2021, the novel coronavirus has infected over 89 million people worldwide and killed over 1.9 million. In the U.S., there have been 22 million people infected and 373,000 deaths. It has never been more important to protect our vulnerable patients and staff from infectious disease, especially during the time they spend in our offices and clinics. It quickly became apparent that there was a need for a dedicated location where patients could be seen that were too ill to be evaluated via telemedicine, but not ill enough to be sent to the Emergency Department (ED). To fill this need, our primary care network developed the Respiratory Evaluation Clinic (REC) concept. These were two geographical locations where the outlying clinics could send potentially infectious patients to evaluate and test COVID-19. Some recommendations, adaptations, lessons learned and the REC clinics' expansions to other locations throughout our network are discussed.

Sign in / Sign up

Export Citation Format

Share Document